WEHRWEIN SVEN 4
4 · AtriCure, Inc. · Filed Nov 26, 2025
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
WEHRWEIN SVEN
Director
Transactions
- Exercise/Conversion
Common Stock
2025-11-24$19.95/sh+5,033$100,408→ 39,407 total - Sale
Common Stock
2025-11-24$37.32/sh−5,033$187,832→ 34,374 total - Exercise/Conversion
Common Stock
2025-11-25$19.95/sh+4,967$99,092→ 39,341 total - Sale
Common Stock
2025-11-25$38.00/sh−4,967$188,746→ 34,374 total - Exercise/Conversion
Non-qualified Stock Option (right to buy)
2025-11-24−5,033→ 29,967 totalExercise: $19.95From: 2017-11-11Exp: 2026-11-11→ Non-qualified Stock Option (right to buy) (5,033 underlying) - Exercise/Conversion
Non-qualified Stock Option (right to buy)
2025-11-25−4,967→ 25,000 totalExercise: $19.95From: 2017-11-11Exp: 2026-11-11→ Non-qualified Stock Option (right to buy) (4,967 underlying)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $37.32 to $38.00 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]These options were granted on November 11, 2016. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.